Tiziana Life Sciences reports positive results for combination of Ozempic and nasal anti-CD3 in study.
Tiziana Life Sciences has reported positive results from a study examining the combination of Ozempic and nasal anti-CD3. This research suggests potential benefits of the drug duo, which could have implications for treatment strategies. Further details about the study's methodology and outcomes were not specified.
October 30, 2024
3 Articles